Weita Lipi Te (维他利匹特)维他利匹特
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 华瑞制药有限公司Chinese legal name: 华瑞制药有限公司
主要成分Active Ingredients
- 注射用水 用适量氢氧化钠调节pHRecorded Chinese composition: 注射用水 用适量氢氧化钠调节pH
- 维生素EWeisheng Su
- 维生素KWeisheng Su
- 用适量氢氧化钠调节pHYongshi Liangqing Yanghua Natiao Jie
药物知识说明
注射用水 用适量氢氧化钠调节pH是一种在国家药监局注册认定的药品。该药品含有维生素e、维生素k-294b69e3等成分。
该药品关联的活性成分包括：维生素e、维生素k。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：华瑞制药有限公司Chinese legal name: 华瑞制药有限公司。
您可以探索含有相同成分的其他药品：维生素e-29ae96d8成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 维他利匹特) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Manufacturers recorded for this product: 华瑞制药有限公司Chinese legal name: 华瑞制药有限公司.
Explore other medicines containing the same ingredient: 维生素e productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 维他利匹特Recorded Chinese name: 维他利匹特
- 规格Specification: 10ml。10 mL
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 华瑞制药有限公司Chinese legal name: 华瑞制药有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H32023138
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H32023138
Manufacturer
Chinese legal name: 华瑞制药有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H32023138
生产企业
华瑞制药有限公司(国产)
适应症
本品为肠外营养不可缺少的组成部分之一，用以满足成人每日对脂溶性维生素A，维生素D2，维生素E，维生素K1的生理需要。
用法用量
1. 成人和11以上儿童一日一支(10ml)。2. 在可配伍性得到保证的前提下，使用前在无菌条件下，将本品加入脂肪乳注射液500ml内，轻轻摇匀后即可输注，并在24小时内用完。3. 本品可用于溶解注射用水溶性维生素。使用前在无菌条件下，将本品10ml加入一瓶注射用水溶性维生素内，溶解后然后再加入脂肪乳注射液中。
不良反应
未进行该项实验且无可靠参考文献。
禁忌
本品含维生素K1，可与香豆素类抗凝血药发生相互作用，不宜合用。
注意事项
1. 必须稀释后静脉滴注。2. 用前1小时配制，24小时内用完。
贮藏
2～10℃避光保存，不能暴露于阳光之下
规格
10ml。
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.